In a study, a team of Korean researchers developed an AI model using OCT images to predict neovascular AMD treatment outcomes after anti-VEGF injections. The model highlights AI’s potential in ...

Shares of Outlook Therapeutics Inc. (NASDAQ:OTLK), were trading at $1.18, down $3.71, or 75%, on word of preliminary data from Norse Eight, the second phase III trial testing ONS-5010, an ophthalmic ...

Opthea Limited (AU:OPT) has released an update. Opthea Limited has achieved significant milestones in its quest to enhance treatment for wet age-related macular degeneration, including the ...

Inflation is still a thing. Prices were 2.6% higher in October than a year earlier, according to the latest Consumer Price Index, released Wednesday. That's a much lower inflation rate than ...

An icon in the shape of a lightning bolt. Impact Link As expected by economic forecasters, inflation heated up in October. The consumer price index sped up as expected to a 2.6% year-over-year ...

The data snapped a streak of six consecutive months of cooling inflation. Consumer prices rose 2.6% in October compared to a year ago, ticking upward from the previous month and reversing some of ...

MELBOURNE, Australia, and PRINCETON, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ: OPT, “Opthea”, the “Company”), a clinical-stage ...

Gregg T. Kokame, MD, MMM, FASRS, will present data from a predefined subgroup of the sozinibercept Phase 2b wet AMD trial related to patients with polypoidal choroidal vasculopathy (PCV), measured at ...

AMD is fighting with itself. The Ryzen 7 9800X3D is the fastest gaming processor you can buy, and I don’t think anyone is surprised by that. It’s even in the running for one of the best ...

The AMD Ryzen 7 9800X3D release date has been officially announced, along with the price and specs of the new chip. This eight-core gaming CPU is the first new Ryzen 9000X3D chip to be released ...

See our ethics statement. AMD has dominated PC gaming CPU performance for more than two years. Its X3D chips have provided a boost that Intel has been unable to match, and its new $479 Ryzen 7 ...

About 10% of people progress to what is described as wet AMD, where abnormal blood vessels begin to grow in the back of the eye. “Today’s action brings to market the first therapeutic option ...